Multi-site clinical study of AI-based solution for cancer diagnosis in breast biopsies

Israeli AI diagnostics firm Ibex detects cancer using advanced algorithms

Multi site study of an AI based solution for prostate cancer detection

Ibex’s and Proscia’s CEOs talk about the recently announced partnership

Digital Pathology & AI in routine clinical practice: From quality control to primary cancer diagnosis

Performance of an AI-based cancer diagnosis system in France’s largest network of pathology institutes

Deployment of a multi-tissue AI-based quality control system in routine clinical workflow

THE LANCET: Blinded external validation study at UPMC for multi-feature AI-algorithm for prostate core needle biopsies

The benefits of implementing AI-Based solutions in pathology

Computer scanning revolution in war on prostate cancer: Thousands of patients could benefit from hi-tech screening that speeds up diagnosis

New AI technology helps pathologists spot cancer

Ibex Medical Analytics CEO shares his story in a podcast with Dr. James Somauroo